PTEN and endometrial cancer: Among the members in a phosphatidylinositol 3-kinase (PI3K) pathway, mutations of PIK3R1 disrupt the genome stabilizing roles of PTEN, potentially synergizing PTEN losses in endometrial cancers [43].